tiprankstipranks
Trending News
More News >
Biocon Limited (IN:BIOCON)
:BIOCON
India Market

Biocon Limited (BIOCON) Stock Statistics & Valuation Metrics

Compare
2 Followers

Total Valuation

Biocon Limited has a market cap or net worth of ₹396.32B. The enterprise value is ―.
Market Cap₹396.32B
Enterprise Value

Share Statistics

Biocon Limited has 1,200,600,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,200,600,000
Owned by Insiders
Owned by Institutions0.07%

Financial Efficiency

Biocon Limited’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)
Return on Assets (ROA)
Return on Invested Capital (ROIC)
Return on Capital Employed (ROCE)
Revenue Per Employee
Profits Per Employee
Employee Count
Asset Turnover
Inventory Turnover

Valuation Ratios

The current PE Ratio of Biocon Limited is ―. Biocon Limited’s PEG ratio is ―.
PE Ratio
PS Ratio0.00
PB Ratio
Price to Fair Value
Price to FCF
Price to Operating Cash Flow
PEG Ratio

Income Statement

In the last 12 months, Biocon Limited had revenue of 147.56B and earned 10.22B in profits. Earnings per share was 8.55.
Revenue147.56B
Gross Profit91.73B
Operating Income50.83B
Pretax Income15.25B
Net Income10.22B
EBITDA41.53B
Earnings Per Share (EPS)8.55

Cash Flow

In the last 12 months, operating cash flow was 16.08B and capital expenditures 0.00, giving a free cash flow of 16.08B billion.
Operating Cash Flow16.08B
Free Cash Flow16.08B
Free Cash Flow per Share13.39

Dividends & Yields

Biocon Limited pays an annual dividend of ₹0.5, resulting in a dividend yield of 0.15%
Dividend Per Share₹0.5
Dividend Yield0.15%
Payout Ratio15.37%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.45
52-Week Price Change-2.71%
50-Day Moving Average332.61
200-Day Moving Average348.00
Relative Strength Index (RSI)46.37
Average Volume (3m)106.03K

Important Dates

Biocon Limited upcoming earnings date is Jul 24, 2025, TBA Not Confirmed.
Last Earnings DateMay 8, 2025
Next Earnings DateJul 24, 2025
Ex-Dividend DateJul 04, 2025

Financial Position

Biocon Limited as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio
Quick Ratio
Debt to Market Cap
Net Debt to EBITDA
Interest Coverage Ratio

Taxes

In the past 12 months, Biocon Limited has paid 2.27B in taxes.
Income Tax2.27B
Effective Tax Rate

Enterprise Valuation

Biocon Limited EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales
EV to EBITDA
EV to Free Cash Flow
EV to Operating Cash Flow

Balance Sheet

Biocon Limited has ₹25.74B in cash and marketable securities with ₹163.87B in debt, giving a net cash position of ₹138.13B billion.
Cash & Marketable Securities₹25.74B
Total Debt₹163.87B
Net Cash₹138.13B
Net Cash Per Share₹115.05
Tangible Book Value Per Share

Margins

Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin
Operating Margin
Pretax Margin
Net Profit Margin
EBITDA Margin
EBIT Margin

Analyst Forecast

The average price target for Biocon Limited is ₹377.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹377.50
Price Target Upside8.92% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis